Wangjia Cao

617 total citations · 1 hit paper
7 papers, 457 citations indexed

About

Wangjia Cao is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Wangjia Cao has authored 7 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Epidemiology and 1 paper in Surgery. Recurrent topics in Wangjia Cao's work include Microbial Metabolites in Food Biotechnology (1 paper), Heme Oxygenase-1 and Carbon Monoxide (1 paper) and Medicinal Plant Pharmacodynamics Research (1 paper). Wangjia Cao is often cited by papers focused on Microbial Metabolites in Food Biotechnology (1 paper), Heme Oxygenase-1 and Carbon Monoxide (1 paper) and Medicinal Plant Pharmacodynamics Research (1 paper). Wangjia Cao collaborates with scholars based in China, United States and Macao. Wangjia Cao's co-authors include Na Lu, Yue Cao, Yangmin Qiu, Yifei Jia, Dongsheng Bai, Yue Zhao, Yuan Gao, Yuxin Zhou, Chunyang Gu and Chen Zhou and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Pharmacology and Cancer Letters.

In The Last Decade

Wangjia Cao

7 papers receiving 457 citations

Hit Papers

The Application of Ferroptosis in Diseases 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Application of Ferroptosis in Diseases
    2020 328 citations Yangmin Qiu, Yue Cao et al. Pharmacological Research profile →

Peers

Wangjia Cao
Ren Zhao China
Lijing Tang China
Yangmin Qiu China
Jiaxian Yu China
Xiangming Ji United States
Yongzhou Huang China
Qin Tan China
Xiaotian Xu China
Ren Zhao China
Wangjia Cao
Citations per year, relative to Wangjia Cao Wangjia Cao (= 1×) peers Ren Zhao

Countries citing papers authored by Wangjia Cao

Since Specialization
Citations

This map shows the geographic impact of Wangjia Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangjia Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangjia Cao more than expected).

Fields of papers citing papers by Wangjia Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangjia Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangjia Cao. The network helps show where Wangjia Cao may publish in the future.

Co-authorship network of co-authors of Wangjia Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Wangjia Cao. A scholar is included among the top collaborators of Wangjia Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangjia Cao. Wangjia Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bhat, Raksha R., Suhas Vasaikar, Sarmistha Nanda, et al.. (2025). Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancer. British Journal of Pharmacology. 182(11). 2524–2541. 2 indexed citations
2.
Cao, Wangjia, et al.. (2023). Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead. International Journal of Molecular Sciences. 24(20). 15249–15249. 4 indexed citations
3.
Bai, Dongsheng, Lei Qi, Wangjia Cao, et al.. (2022). The flavonoid GL‐V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells. British Journal of Pharmacology. 180(8). 1072–1089. 9 indexed citations
4.
5.
Bai, Dongsheng, et al.. (2021). ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation. Autophagy. 18(7). 1673–1693. 42 indexed citations
6.
Qiu, Yangmin, Yue Cao, Wangjia Cao, Yifei Jia, & Na Lu. (2020). The Application of Ferroptosis in Diseases. Pharmacological Research. 159. 104919–104919. 328 indexed citations breakdown →
7.
Cao, Yue, Wangjia Cao, Yangmin Qiu, et al.. (2020). Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis. Pharmacological Research. 159. 104981–104981. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ren Zhao Breakdown of academic impact, for papers by Lijing Tang Breakdown of academic impact, for papers by Yangmin Qiu Breakdown of academic impact, for papers by Jiaxian Yu Breakdown of academic impact, for papers by Xiangming Ji Breakdown of academic impact, for papers by Yongzhou Huang Breakdown of academic impact, for papers by Qin Tan Breakdown of academic impact, for papers by Xiaotian Xu
Rankless by CCL
2026